Screener
Tarsus Pharmaceuticals, Inc. TARS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow?
- Tarsus Pharmaceuticals, Inc. (TARS) reported free cash flow of $57.15M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s free cash flow increased by 288.1% year-over-year, from -$30.39M to $57.15M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s free cash flow?
- Over 2 years (2022 to 2024), Tarsus Pharmaceuticals, Inc.'s free cash flow has grown at a 30.7% compound annual growth rate (CAGR), from -$49.54M to -$84.59M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude